Major Complications After Liver Transplant

Liver transplantation trades one life-threatening disease for a period of intense physiologic vulnerability. The operation itself is only the opening chapter; what follows is a prolonged phase where bile ducts must drain properly, blood vessels must remain open, the immune system must be restrained but not silenced, and every organ system must adapt to a new metabolic center. Clinicians group complications into recognizable categories not to oversimplify, but to impose order on a complex recovery. These categories—biliary, vascular, immunologic, infectious, renal, and surgical—are tracked because each has characteristic timing, warning signs, and intervention windows. Understanding them helps patients recognize when symptoms are urgent and helps families appreciate why transplant follow-up is so structured and frequent. [1] [2]

Biliary complications are among the most common and frustrating problems after liver transplantation because bile ducts are delicate, variable, and exquisitely sensitive to blood flow. Leaks and strictures may appear weeks to months after surgery and often announce themselves subtly—rising alkaline phosphatase, mild jaundice, vague abdominal discomfort—before becoming clinically obvious. The risk profile depends strongly on graft type: living-donor and split grafts have higher biliary complication rates than whole deceased-donor grafts, reflecting smaller ducts and more complex reconstructions. Donation after circulatory death grafts carry a distinct risk of ischemic cholangiopathy, where diffuse bile duct injury can evolve despite an initially functioning graft. Management frequently involves repeated endoscopic procedures, stenting, antibiotics, and prolonged surveillance, and in severe cases biliary injury becomes a leading cause of graft failure and retransplantation. Because biliary disease often unfolds slowly, persistence and close monitoring—not dramatic symptoms—are what protect outcomes. [3] [4]

Vascular complications represent the high-stakes emergencies of liver transplantation. Thrombosis of the hepatic artery, portal vein, or hepatic veins can deprive the graft of oxygen or outflow, leading to rapid graft dysfunction or loss. These events are most common early after surgery, when surgical anastomoses are fresh and coagulation balance is unstable, but late vascular problems can occur as well. Hepatic artery thrombosis is particularly feared because the bile ducts depend almost entirely on arterial blood supply; when flow is lost, biliary necrosis and sepsis may follow even if liver enzymes initially look modest. Diagnosis relies on vigilance—Doppler ultrasound, CT angiography, and low thresholds for investigation when labs or symptoms change. Treatment ranges from urgent re-operation or endovascular intervention to emergent retransplantation. For patients, the message is simple but critical: sudden pain, fever, hypotension, or abrupt laboratory deterioration after transplant is never “normal recovery” and demands immediate evaluation. [2] [5]

Rejection is not a failure of surgery but a predictable consequence of immune recognition. Acute cellular rejection commonly occurs within the first months after transplant and may present only as abnormal liver tests, while chronic rejection evolves insidiously with progressive bile duct loss and graft dysfunction. Modern immunosuppression has transformed rejection from a frequent cause of graft loss into a largely manageable condition, but that success comes with balance: too little suppression invites rejection, too much invites infection, malignancy, and metabolic toxicity. Antibody-mediated rejection, once considered rare in liver transplantation, is increasingly recognized and requires specialized testing and targeted therapy. Long-term immunologic management is therefore dynamic, not static; drug levels, side effects, infections, and kidney function all feed back into dosing decisions. For patients, adherence and communication are central themes—missed doses or unreported side effects can tip the immune balance in ways that only become apparent weeks later. [6] [7]

Infection risk after liver transplant follows a recognizable timeline shaped by immunosuppression intensity and exposure. Early infections often reflect surgical stress and hospital organisms; intermediate infections include opportunistic pathogens such as cytomegalovirus; and late infections resemble community-acquired illness but may be more severe. Fever may be muted, and classic inflammatory signs can be absent, so clinicians rely heavily on vigilance and low thresholds for testing. Prophylactic strategies—antivirals, antifungals, vaccinations—are integral parts of transplant care, not optional extras. Infections remain a leading cause of morbidity and mortality after transplantation, particularly when diagnosis is delayed. For patients and caregivers, this means reporting subtle changes—fatigue, confusion, cough, urinary symptoms—promptly rather than waiting for dramatic illness. Infection control is not about fear; it is about recognizing that immunosuppression rewrites the rules of what “mild” symptoms mean. [8] [9]

Kidney dysfunction is one of the most consequential long-term complications after liver transplantation, often emerging from a convergence of pre-existing disease, perioperative injury, and chronic immunosuppressive toxicity. Calcineurin inhibitors, while central to rejection prevention, are nephrotoxic and require careful titration over years. Acute kidney injury in the immediate post-operative period may recover, but repeated insults can push patients into chronic kidney disease, altering quality of life and long-term survival. Monitoring trends—rather than single creatinine values—is essential, and many programs now adopt kidney-sparing immunosuppression strategies when feasible. For patients, hydration, avoidance of nephrotoxic medications, and routine lab surveillance become lifelong disciplines. Renal dysfunction often advances quietly, making structured follow-up the difference between manageable decline and irreversible loss. [10] [6]

Surgical complications extend beyond the operating room and into months or years of recovery. Early issues include bleeding, wound infections, bile peritonitis, and cardiopulmonary instability, while later problems include incisional hernias, adhesions, and bowel obstruction. Many of these complications reflect the physiologic burden of advanced liver disease—coagulopathy, malnutrition, portal hypertension—rather than surgical error. The distinction matters because prevention focuses on optimization: nutrition, mobility, respiratory care, and careful medication management. Incisional hernias, for example, are common and often repaired electively once recovery stabilizes. For patients, recognizing surgical complications as part of a continuum rather than isolated mishaps helps frame recovery realistically. Healing after liver transplant is not linear; it is a series of adjustments that reward patience, vigilance, and partnership with the transplant team. [1] [11]